This recorded lecture was part of our 2025 Free Webinar Series and sponsored by Agepha Pharma and Rated Doctor, presented by Dr. Yasmine Abdalla. Age-related macular degeneration (AMD) advances through early, intermediate, and late stages. While anti-VEGF therapies are effective for wet AMD, there are no approved treatments currently available for dry AMD in the UK. Emerging approaches, including sustained-release anti-VEGF, gene therapy, and complement inhibitors, offer hope for dry AMD. This recorded lecture explores cutting-edge advancements and strategies to preserve vision.

By completing this course, you submit your information to CPDpoints.com and the sponsors, who will use it to communicate with you regarding this module and their other services.